Drug
Zenocutuzumab
Zenocutuzumab: highest development phase Phase 2, developed by Merus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merus
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zenocutuzumab NCT03321981 | Phase 2 | Breast Cancer Metastatic |
Latest
No recent events.
Follow Zenocutuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.